Clinical Briefing Report

Adobe Stock
Lori Solomon
1 min read
Rybrevant Faspro is the first approval in 10 years for recurrent, metastatic disease after platinum-based chemotherapy and immunotherapy
Adobe Stock
Elana Gotkine
2 min read
Second study shows that prevalence and incidence of EoE have increased since 2009, and that males are more likely to have EoE
Read More